GENSIGHT BIOLOGICS S.A. (EPA:SIGHT) | WebDisclosure

Basculer en Français

9478	Companies
185482	Keywords
117825	Articles
99322	Press releases

Headlines Articles Press releases GENSIGHT BIOLOGICS S.A.

Home
Companies
GENSIGHT BIOLOGICS S.A.

BRIEF

published on 07/17/2025 at 08:05, 4 months 19 days ago

GenSight Biologics lève 500 000 euros pour renforcer son développement

Financement GenSight Biologics Thérapies Géniques Phase III LUMEVOQ
PRESS RELEASE

published on 07/17/2025 at 08:00, 4 months 19 days ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
GenSight Biologics annonce un financement complémentaire d'environ 500 000 euros par un actionnaire existant. Nouveaux fonds pour développer LUMEVOQ, candidate médicament avancée pour maladies neurodégénératives de la rétine

Financement GenSight Biologics Thérapies Géniques Maladies Neurodégénératives LUMEVOQ
BRIEF

published on 07/03/2025 at 21:24, 5 months 1 day ago

GenSight Biologics boucle un placement privé de près de 4 millions d'euros

Euronext Financement Placement Privé Actions Ordinaires GenSight Biologics
BRIEF

published on 07/03/2025 at 21:24, 5 months 1 day ago

GenSight Biologics completes private placement of nearly €4 million

Private Placement Common Shares Euronext Funding GenSight Biologics
PRESS RELEASE

published on 07/03/2025 at 21:19, 5 months 1 day ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
GenSight Biologics annonce le règlement livraison de son placement privé de près de 4 millions d’euros. Émission d'actions ordinaires et de bons de souscription. Risque financier associé. Contactez-nous pour plus d'informations

Placement Privé Actions Ordinaires Bons De Souscription Risque Financier GenSight Biologics
PRESS RELEASE

published on 07/03/2025 at 21:19, 5 months 1 day ago

Inside Information / Operations of the issuer (acquisitions, sales...)
GenSight Biologics closes EUR 3.9M private placement with issuance of ordinary shares, pre-funded warrants, investor warrants. Funds to repay convertible bonds. Maxim Group, LLC acted as placement agent

Private Placement Ordinary Shares GenSight Biologics Maxim Group EUR 3.9M
BRIEF

published on 07/01/2025 at 08:59, 5 months 4 days ago

GenSight Biologics lève près de 4 millions d'euros lors d'un placement privé

Investissement Placement Privé GenSight Biologics LUMEVOQ® Actions Euronext
BRIEF

published on 07/01/2025 at 08:59, 5 months 4 days ago

GenSight Biologics raises nearly €4 million in private placement

Private Placement Investment GenSight Biologics Euronext Shares LUMEVOQ ®
PRESS RELEASE

published on 07/01/2025 at 08:54, 5 months 4 days ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
GenSight Biologics réalise avec succès un placement privé d'un montant de près de 4 millions d'euros pour financer le développememt de LUMEVOQ® et des initiatives réglementaires, tout en honorant les obligations financières

Financement Placement Privé GenSight Biologics Thérapies Géniques LUMEVOQ
PRESS RELEASE

published on 07/01/2025 at 08:54, 5 months 4 days ago

Inside Information / Operations of the issuer (acquisitions, sales...)
GenSight Biologics successfully completes private placement of nearly EUR 4 million, attracting new international investors. Funds to advance gene therapies for retinal diseases and CNS disorders

Private Placement GenSight Biologics Gene Therapies Retinal Diseases CNS Disorders

Accesswire

Published on 12/05/2025 at 15:25, 9 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 34 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 34 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 34 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 59 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 15:05, 29 minutes ago

Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 1 hour 11 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 1 hour 17 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 24 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 49 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings

Les Echos

Published on 12/05/2025 at 15:10, 23 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 23 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 1 hour 35 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 49 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 49 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE